Efficacy and Safety of Fremanezumab Further Displayed: Stephanie J. Nahas, MD
April 19th 2021The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University discussed 2 research projects she led presented at AAN 2021 on the efficacy and safety of fremanezumab.
AUPN Leadership Minute Episode 9: Engaging Medical Students in Neurology – Part 2
April 16th 2021Episode 9 of the AUPN Leadership Minute features Donald S. Higgins, Jr., MD, of the Veterans Health Administration; and Douglas J. Gelb, MD, PhD, of the University of Michigan [WATCH TIME: 5 minutes]
Plasma NfL Offers Better Prognostication for Neurodegeneration Than Total Tau
April 16th 2021Data from a cohort of more than 900 individuals suggest that while total tau can add cross-sectional value in certain contexts, neurofilament light served better for prognostication of cognitive decline and imaging changes.
Investigators Identify Links Between Clinical Seizure Characteristics and Continuous EEG
April 16th 2021Critically ill patients who were obtunded, stuporous, or comatose had pediatric lateralized epileptiform discharges, and acute brain insults were among many clinical characteristics to benefit from longer EEG.
Cortical Hyperexcitability More Prominent in Cognitive Impaired ALS
April 15th 2021According to the study authors, future longitudinal studies assessing the evolution of cognitive and cortical excitability changes may provide a greater understanding of the importance of cortical circuits in ALS pathogenesis.